Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$WST Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $2.17 up 19.23% YoY • Reported revenue of $872.3M up 13.80% YoY • West Pharmaceutical Services, Inc. expects full-year 2026 net sales of $3.345 billion to $3.380 billion and adjusted-diluted EPS of $8.85 to $9.05, while third-quarter 2026 adjusted-diluted EPS is $2.14 to $2.24.

Price since post

Full Details

Advertisement|Remove ads.